Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Discover how Anisina, a first-in-class drug targeting cancer's cytoskeleton, enhances chemotherapy effectiveness by 20-fold in neuroblastoma treatment.